Rhabdomyosarcoma Clinical Trials
132 clinical trials for Rhabdomyosarcoma across international registries, including 32 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) — RECRUITING · PHASE1
- Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors — RECRUITING · PHASE1
- Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors — RECRUITING · PHASE1
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors — RECRUITING · PHASE1
- A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS) — RECRUITING · PHASE3
- FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma — RECRUITING · PHASE1
- Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma — RECRUITING · NA
- Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors — RECRUITING · PHASE1
- Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors — RECRUITING · PHASE1
- Familial Investigations of Childhood Cancer Predisposition — RECRUITING
- Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease — RECRUITING · PHASE2
- VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors — RECRUITING · PHASE1
- B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) — RECRUITING · PHASE1
- Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors — RECRUITING · PHASE1
- Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) — RECRUITING · PHASE1
- Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas — RECRUITING · PHASE1
- Tumor-Lymph Node Mapping — RECRUITING
- Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies — RECRUITING · PHASE1
- Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas — RECRUITING · PHASE1
- Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells — RECRUITING · PHASE1
- HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma — RECRUITING · PHASE1
- Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells — RECRUITING · PHASE1
- Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors — RECRUITING · PHASE1
- Ivonescimab in the Treatment of Multiple Advanced Tumors — RECRUITING · PHASE2
- Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry — RECRUITING
- A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors. — RECRUITING · PHASE3
- Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors — RECRUITING · PHASE2
- Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen — RECRUITING · PHASE1
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma — RECRUITING · PHASE1
- A PROSPECTIVE PHASE 3 STUDY OF PATIENTS WITH NEWLY DIAGNOSED VERY LOW-RISK AND LOW-RISK FUSION NEGATIVE RHABDOMYOSARCOMA — RECRUITING · PHASE3
- A RANDOMIZED PHASE 3 TRIAL OF VINORELBINE, DACTINOMYCIN, AND CYCLOPHOSPHAMIDE (VINO-AC) PLUS MAINTENANCE CHEMOTHERAPY WITH VINORELBINE AND ORAL CYCLOPHOSPHAMIDE (VINO-CPO) VS VINCRISTINE, DACTINOMYCIN AND CYCLOPHOSPHAMIDE (VAC) PLUS VINO-CPO MAINTENANCE IN PATIENTS WITH HIGH RISK RHABDOMYOSARCOMA (HR-RMS) — RECRUITING · PHASE3
- A RANDOMIZED PHASE 3 STUDY OF VINCRISTINE, DACTINOMYCIN, CYCLOPHOSPHAMIDE (VAC) ALTERNATING WITH VINCRISTINE AND IRINOTECAN (VI) VERSUS VAC/VI PLUS TEMSIROLIMUS (TORI, TORISEL, NSC# 683864, IND# 122782) IN PATIENTS WITH INTERMEDIATE RISK (IR) RHABDOMYOSARCOMA (RMS) — RECRUITING · PHASE3
- Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models — COMPLETED
- Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma — ACTIVE_NOT_RECRUITING · PHASE3
- Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
- Radiological Diagnosis of Pediatric Neck Swellings — ACTIVE_NOT_RECRUITING
- Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors — ACTIVE_NOT_RECRUITING · PHASE2
- Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma — ACTIVE_NOT_RECRUITING · PHASE1
- Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma — NOT_YET_RECRUITING · NA
- Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE2
- Methionine PET/CT Studies In Patients With Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- Detection of bone marrow metastases by FDG-PET/CT in patients with rhabdomyosarcomas — OTHER
- B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1
- my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults — NOT_YET_RECRUITING · NA
- Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants — ACTIVE_NOT_RECRUITING · PHASE1
- Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma — COMPLETED · PHASE2
- Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas — ACTIVE_NOT_RECRUITING · PHASE1
- Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors — SUSPENDED · PHASE1
- Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
- Radiation Therapy to Treat Musculoskeletal Tumors — ACTIVE_NOT_RECRUITING · PHASE2
Refine this search